Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,031 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.
de Botton S, Coiteux V, Chevret S, Rayon C, Vilmer E, Sanz M, de La Serna J, Philippe N, Baruchel A, Leverger G, Robert A, San Miguel J, Conde E, Sotto JJ, Bordessoule D, Fegueux N, Fey M, Parry A, Chomienne C, Degos L, Fenaux P. de Botton S, et al. Among authors: san miguel j. J Clin Oncol. 2004 Apr 15;22(8):1404-12. doi: 10.1200/JCO.2004.09.008. J Clin Oncol. 2004. PMID: 15084614 Clinical Trial.
Therapy-related acute promyelocytic leukemia.
Beaumont M, Sanz M, Carli PM, Maloisel F, Thomas X, Detourmignies L, Guerci A, Gratecos N, Rayon C, San Miguel J, Odriozola J, Cahn JY, Huguet F, Vekhof A, Stamatoulas A, Dombret H, Capote F, Esteve J, Stoppa AM, Fenaux P. Beaumont M, et al. Among authors: san miguel j. J Clin Oncol. 2003 Jun 1;21(11):2123-37. doi: 10.1200/JCO.2003.09.072. J Clin Oncol. 2003. PMID: 12775738
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
de Botton S, Fawaz A, Chevret S, Dombret H, Thomas X, Sanz M, Guerci A, San Miguel J, de la Serna J, Stoppa AM, Reman O, Stamatoulas A, Fey M, Cahn JY, Sotto JJ, Bourhis JH, Parry A, Chomienne C, Degos L, Fenaux P. de Botton S, et al. Among authors: san miguel j. J Clin Oncol. 2005 Jan 1;23(1):120-6. doi: 10.1200/JCO.2005.03.127. Epub 2004 Nov 8. J Clin Oncol. 2005. PMID: 15534358
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial.
De Botton S, Chevret S, Sanz M, Dombret H, Thomas X, Guerci A, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Cony Makhoul P, Travade P, Solary E, Fegueux N, Bordessoule D, San Miguel J, Link H, Desablens B, Stamatoullas A, Deconinck E, Geiser K, Hess U, Maloisel F, Castaigne S, Preudhomme C, Chomienne C, Degos L, Fenaux P; European APL Group. De Botton S, et al. Among authors: san miguel j. Br J Haematol. 2000 Dec;111(3):801-6. doi: 10.1046/j.1365-2141.2000.02442.x. Br J Haematol. 2000. PMID: 11122141 Free article. Clinical Trial.
Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial.
de Botton S, Chevret S, Coiteux V, Dombret H, Sanz M, San Miguel J, Caillot D, Vekhoff A, Gardembas M, Stamatoulas A, Conde E, Guerci A, Gardin C, Fey M, Cony Makhoul D, Reman O, de la Serna J, Lefrere F, Chomienne C, Degos L, Fenaux P; European APL group. de Botton S, et al. Among authors: san miguel j. Leukemia. 2003 Feb;17(2):339-42. doi: 10.1038/sj.leu.2402807. Leukemia. 2003. PMID: 12592333 Clinical Trial.
Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients.
Bladé J, San Miguel JF, Alcalá A, Maldonado J, Sanz MA, García-Conde J, Moro MJ, Alonso C, Besalduch J, Zubizarreta A, et al. Bladé J, et al. Among authors: san miguel jf. J Clin Oncol. 1993 Jun;11(6):1165-71. doi: 10.1200/JCO.1993.11.6.1165. J Clin Oncol. 1993. PMID: 8501503 Clinical Trial.
Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.
Bladé J, San Miguel JF, Fontanillas M, Alcalá A, Maldonado J, García-Conde J, Conde E, Conzález-Brito G, Moro MJ, Escudero ML, Trujillo J, Pascual A, Rozman C, Estapé J, Montserrat E. Bladé J, et al. Among authors: san miguel jf. J Clin Oncol. 1996 Jul;14(7):2167-73. doi: 10.1200/JCO.1996.14.7.2167. J Clin Oncol. 1996. PMID: 8683251 Clinical Trial.
Two new 3' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemia.
Chillón MC, González M, García-Sanz R, Balanzategui A, González D, López-Pérez R, Mateos MV, Alaejos I, Rayón C, Arbeteta J, Hernández JM, Orfao A, San Miguel J. Chillón MC, et al. Among authors: san miguel j. Genes Chromosomes Cancer. 2000 Jan;27(1):35-43. Genes Chromosomes Cancer. 2000. PMID: 10564584
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience.
Rodríguez J, Caballero MD, Gutiérrez A, Marín J, Lahuerta JJ, Sureda A, Carreras E, León A, Arranz R, Fernández de Sevilla A, Zuazu J, García-Laraña J, Rifon J, Varela R, Gandarillas M, SanMiguel J, Conde E. Rodríguez J, et al. Ann Oncol. 2003 Dec;14(12):1768-75. doi: 10.1093/annonc/mdg459. Ann Oncol. 2003. PMID: 14630683 Free article. Clinical Trial.
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience.
Rodriguez J, Caballero MD, Gutierrez A, Solano C, Arranz R, Lahuerta JJ, Sierra J, Gandarillas M, Perez-Simon JA, Zuazu J, Lopez-Guillermo A, Sureda A, Carreras E, Garcia-Laraña J, Marin J, Garcia JC, Fernandez De Sevilla A, Rifon J, Varela R, Jarque I, Albo C, Leon A, SanMiguel J, Conde E. Rodriguez J, et al. Ann Oncol. 2004 Oct;15(10):1504-9. doi: 10.1093/annonc/mdh391. Ann Oncol. 2004. PMID: 15367411 Free article.
1,031 results